MedElevator Войти в исследования
← Поиск публикаций

DOI 10.26574/maedica.2024.19.2.417

Медицинская библиотека · Maedica · 2024

Neoadjuvant Chemotherapy: Friend or Foe.

Popa Cristian Nicolae, Bratu Vladimir Dan, Popa Elisa Cristina, Dinu Daniela Elena, Iosif Cristina, Chirita Evelina, Mates Ioan Nicolae

Клинический случайСтатьяПеревод в очереди

Аннотация

INTRODUCTION

Most breast cancers require neoadjuvant chemotherapy and the response to primary systemic therapy (PST) is crucial for deciding on the surgical technique and predicting patient outcomes. However, chemotherapy also brings numerous side effects, with cardiovascular issues being some of the most significant, common and challenging to manage.

CASE PRESENTATION: We present the case of a 71-year-old woman diagnosed with stage T2N1M0 Luminal B breast cancer. It was decided to initiate chemotherapy consisting of four cycles of FEC (5-fluorouracil 600 mg/m² on days 1 and 8, epirubicin 60 mg-90 mg/m² and cyclophosphamide 600 mg/m²), followed by four cycles of docetaxel (75 mg/m² every three weeks). Near the end of the treatment cycles, she developed new-onset angina with complex critical coronary lesions. This required assembling a multidisciplinary team to determine the optimal management strategy from cardiological, surgical, and oncological standpoints. Just when we thought we had found the optimal approach for managing ischemic heart disease, the situation became more complicated with the development of deep vein thrombosis, requiring a reassessment of the entire treatment plan.

CONCLUSIONS

Neoadjuvant chemotherapy is an important weapon against breast cancer but also a veritable enemy of cardiovascular diseases. The association of two major diseases requires a multidisciplinary team capable of making the best decisions to maximize benefits and minimize adverse effects.

Для цитирования: Popa Cristian Nicolae, Bratu Vladimir Dan, Popa Elisa Cristina, Dinu Daniela Elena, Iosif Cristina, Chirita Evelina, Mates Ioan Nicolae. Neoadjuvant Chemotherapy: Friend or Foe.. Maedica. 2024. DOI: 10.26574/maedica.2024.19.2.417.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.